Study on cytoprotective effects of tocotorienol in a cellular Parkinson's disease model
| Project/Area Number |
23580168
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Food science
|
|---|
| Research Institution | Tottori University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
NAKASO Kazuhiro 鳥取大学, 医学部, 准教授 (30379648)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
Fiscal Year 2013: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | トコトリエノール / パーキンソン病 / αシヌクレイン / 非抗酸化作用 / シグナル伝達 / カベオリン |
|---|
| Research Abstract |
In the present study, we investigated the cytoprptective effects of tocotrienol (T3) in cellular and murine Parkinson's disease (PD) models. All T3 homologues exerted cytoprptective effects via activation of PI3K/Akt signaling pathway in a cellular PD model. We also identified estrogen receptor (ER) beta as an upstream mediator of PI3K/Akt signaling and demonstrated the direct binding of T3 to ER beta in vitro. Furthermore, we revealed that T3 treatment relieved PD-related symptoms in PD model mice.
Our data have demonstrated that T3 elicits the cytoprotective effects via ER beta/PI3K/Akt signaling pathway in cellular and murine PD models.
|
Report
(4 results)
Research Products
(23 results)
